Dasher Neuroscience Holdings Inc

As of June 30, 2026, Dasher Neuroscience Holdings Inc carries a market capitalization of 3.93B, placing it among publicly traded companies globally. Its enterprise value stands at 2.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Dasher Neuroscience Holdings Inc has 99.39M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Dasher Neuroscience Holdings Inc maintains a current ratio of 32.84, meaning it holds 32.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Dasher Neuroscience Holdings Inc's stock has declined approximately 12.75% over the past 52 weeks. The 50-day moving average sits at 51.37, while the 200-day moving average is 48.62.

As of June 30, 2026, Dasher Neuroscience Holdings Inc holds 1.08B in cash and equivalents against 408,000.00 in total debt, resulting in a net debt position of -1.08B. Total book value stands at 1.07B, with working capital of 1.05B providing operational flexibility.

Dasher Neuroscience Holdings Inc's most recent stock split took place on November 10, 2025 with a 613:644 split ratio.